A lower starting dose of eltrombopag is efficacious in Japanese patients with previously treated chronic immune thrombocytopenia

Y. Tomiyama, Y. Miyakawa, S. Okamoto, S. Katsutani, A. Kimura, Y. Okoshi, H. Ninomiya, H. Kosugi, S. Nomura, K. Ozaki, Y. Ikeda, T. Hattori, K. Katsura, Y. Kanakura

Research output: Contribution to journalArticle

37 Citations (Scopus)

Fingerprint Dive into the research topics of 'A lower starting dose of eltrombopag is efficacious in Japanese patients with previously treated chronic immune thrombocytopenia'. Together they form a unique fingerprint.

Medicine & Life Sciences